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Abstract
We consider a stochastic mathematical program with equilibrium constraints (SMPEC), and show that under
certain assumptions, global optima and stationary solutions are robust with respect to changes in the underlying
probability distribution. In particular, the discretization scheme Sample Average Approximation, which is con-
vergent for both global optima and stationary solutions, can be combined with the robustness result to motivate
the use of SMPECs in practice.
We also consider SMPECs with multiple objectives, and establish robustness of weakly Pareto optimal and
stationary solutions.
Two applications are presented, both principally and numerically, in order to exemplify the use of SMPECs:
a classic trafﬁc network design problem where travel costs are uncertain, and the optimization of a treatment plan
in intensity modulated radiation therapy, where radiobiological parameters are uncertain.
Keywords: stochasticmathematicalprogramwithequilibriumconstraints, solutionstabilityandrobustness, inten-
sity modulated radiation therapy, trafﬁc network design, sample average approximation, weakly Pareto optimality
1 Introduction
A physical system is often subjected to uncertainties, such as uncertain material parameters in a structural problem,
and a stochastic market in an application in economics. Although it may be sufﬁcient to consider a representative,
e.g., a “mean”, value of the uncertain parameters in order to produce a simulation of the system, the solution to an
optimization problem that is based on its response can be very sensitive; using mean values of uncertain parameters
can then give suboptimal solutions.
There are two main approaches to incorporating uncertainty into optimization models. In Stochastic Program-
ming (SP) (see, e.g., [26, 7]), the objective function is an expected value, sometimes in combination with a risk
measure. In such models, either all the decisions are made before any realization of the uncertain data, or the model
contains a recourse opportunity so that some decisions can be made at a second stage. In ’Robust Optimization’
(RO), an optimal solution is required to be feasible for all realizations of the uncertain data. The probability dis-
tributions utilized in stochastic programming are here replaced by requirements that parameter values are conﬁned
to special bounded sets. Robust optimization provides a guarantee that an optimal solution is “safe”, but it is a
pessimistic approach, since it considers the worst-case scenario. It is tractable for certain convex problems (see
[4]); it has, however, also been utilized for non-convex problems through a linearization of the constraints ([63]).
We are interested in several applications which all can be modeled as a mathematical program with equilibrium
constraints (MPEC). The stochastic extension of MPEC is a stochastic mathematical program with equilibrium
constraints (SMPEC) ([47]), and the focus of this paper is to analyze the stability of optimal and stationary so-
lutions to SMPEC when the underlying probability distribution is itself uncertain. This is motivated by practical
applications such as the optimization of treatment plans in radiation therapy, where the biological response to
radiation depends on parameters of which the probability distribution is uncertain.
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1We will show that the SMPEC model is robust under certain conditions, and we will also show how to dis-
cretize a continuous distribution using Sample Average Approximation (SAA), and that such an approximation
will converge. Not surprisingly, similar conditions are required for robustness as for convergence of SAA.
The quantitative stability of solutions to stochastic programs due to changes in the probability distribution has
been studied in R¨ omisch [49] for general stochastic programs, for convex programs in R¨ omisch and Wets [50],
and for multistage programs in Heitsch et al. [25]. The focus is on the Lipschitz continuity of global optimal
objective values. Our approach, in contrast, is qualitative in nature, and provide stability results on optimal as well
as stationary solutions.
The subject of optimality conditions of SMPECs and of their numerical solution has been studied previously,
for example by Lin et al. [32], Birbil et al. [6], and by Shapiro [53]. We follow the original formulation of the
SMPEC appearing in Patriksson and Wynter [47].
The remainder of this paper is organized as follows. In Section 2, we introduce the SMPEC and present two
applications: trafﬁc network design and the optimization of a treatment plan utilizing intensity modulated radiation
therapy (IMRT). In Section 3, we derive conditions under which global optima and stationary solutions are stable
with respect to perturbations in the probability distribution. In Section 4, we present a discretization scheme,
and show that it converges when the discretization is reﬁned. Combining stability with a convergent discretization
scheme motivates the use of SMPEC in practice. In Section 5, we present two numerical examples, and in Section 6
we extend the stability result to SMPECs with multiple objectives. Finally, in Section 7, we provide a summary
and future research opportunities.
2 Stochastic mathematical programs with equilibrium constraints
2.1 Mathematical programs with equilibrium constraints
Consider a mathematical program with an equilibrium constraint in the form of a variational inequality:
(MPEC)
8
> > <
> > :
minimize
(x,y)
f(x,y),
subject to x ∈ X,
−F(x,y) ∈ NC(y),
where f : Rn×Rm → R, y ∈ Rm, C ⊆ Rm is a polyhedron, F(x,·) :C → Rm is smooth, and NC : Rm ¶ Rm is the
standard normal cone mapping
NC(y) :=
( ©
z ∈ Rm|zT(w−y) ≤ 0, w ∈C
ª
, if y ∈C,
/ 0, otherwise.
The vector x ∈ Rn represents the design (or, primary) variables, and y ∈ Rm the response (or, secondary) variables.
The non-empty, closed and convex set X ⊂ Rn speciﬁes the set of feasible designs. Note that there are no joint
upper-level constraints in this setting, which is natural when considering stability of optimal solutions.
The variational inequality, −F(x,y)∈NC(y), can represent an equilibrium in a general form. For example, with
C = Rm, the variational inequality is equivalent to the system of equations
F(x,y) = 0m,
and with C = Rm
+, the variational inequality is equivalent to the complementarity constraint
0m ≤ y ⊥ F(x,y) ≥ 0m, (1)
where a ⊥ b means that aTb = 0. Since complementarity constraints are examples of equilibrium constraints it
indicates that MPECs are usually very nonlinear and irregular. In fact, MPECs lack standard constraint qualiﬁca-
tions ([51]), which can highly inﬂuence the performance of nonlinear optimization algorithms for solving MPECs.
For recent work on the numerical solution of MPECs we refer to Fletcher et al. [21] and Leyffer et al. [28].
If F(x,y) = Ñyf(x,y) for a C1 function f(x,·), then the variational inequality
Ñf(x,y)T(¯ y−y) ≥ 0, ∀¯ y ∈C,
2represents the optimality conditions for the parametric optimization problem to
minimize
y∈C
f(x,y),
and the MPEC becomes what is traditionally known as a bilevel optimization problem ([2]).
The generality of the variational inequality suggests that a number of optimization problems can be put into the
form of (MPEC) (see [34, 43, 5]). For example, the Stackelberg game [56], which is a leader-follower game, and
an extension of the Nash game [40] can be formulated as an MPEC. In the following we will present two additional
applications.
2.2 Stochastic mathematical program with equilibrium constraints
Next, we consider the stochastic extension of (MPEC). Let (W,Q,P) be a complete probability space, and consider
the problem to
(SMPECW)
8
> > > <
> > > :
minimize
(x,y(·))
Ew[f(x,y(w),w)] :=
Z
W
f(x,y(w),w)P(dw),
subject to x ∈ X,
−F(x,y,w) ∈ NC(y), P-a.s.,
where y : W → Rm is a random element of the probability space (W,Q,P). We also introduce S : Rn ×W ¶ Rm
which deﬁnes the set of solutions to the lower-level parametric variational inequality problem,
S(x,w) := {y ∈ Rm | −F(x,y,w) ∈ NC(y)}. (2)
In view of stochastic programming with recourse, SMPEC is considered as a here-and-now type of problem, where
decisions x should be taken before any realizations of uncertain data.
When the solution to the lower-level problem is non-unique for a ﬁxed x and w, the model should be interpreted
as y being chosen such that the objective function is minimized given x and w.
This formulation of SMPEC follows that of Patriksson and Wynter [47], and Evgrafov and Patriksson [20].
Lin et al. [31] consider a formulation which contains a variational inequality with a recourse variable which is
penalized. Birbil et al. [6] consider the following formulation:
(ESMPECW)
8
> > <
> > :
minimize
(x,y)
Ew[f(x,y,w)],
subject to x ∈ X,
−Ew[F(x,y,w)] ∈ NC(y),
which means that y solves the lower-level problem in a mean sense.
2.3 Existence of optimal solutions
The following assumptions will be in force throughout this paper:
Assumptions A
(A1) The mapping S(x,·) is measurable for any x;
(A2) the set X is closed; and the mapping x 7→ S(x,w) is closed for almost any w ∈ W;
(A3) the function f is continuous in (x,y), measurable in w, uniformly weakly coercive with respect to x over the
set X, and bounded from below by a (Q,P)-integrable function;
(A4) the set S(x0,w) is nonempty for some x0 ∈ X and almost any w ∈ W.
The following result on the existence of optimal solutions is due to Evgrafov and Patriksson [20].
Theorem 2.1 (existence of optimal solutions) Suppose that Assumptions (A) hold. Then, the problem (SMPECW)
has at least one optimal solution.
32.4 Applications
We consider two applications: trafﬁc network design, and the optimization of a treatment plan for radiation therapy.
We will utilize them both to motivate the assumptions we make in our robustness theorems, and in numerical
examples in Section 5.
Trafﬁc network design We consider a road trafﬁc model. The network is represented by a strongly connected
graph G = (V ,E), where V is the set of nodes and E is the set of directed links. For each origin–destination (OD)
pair (p,q) ∈ C with C ⊂ V ×V , there is a transportation demand. Each route r ∈ Rpq joining OD pair (p,q), has
an associated ﬂow hr and a travel cost cr.
We assume that the design parameter x ∈Rn inﬂuences the travel cost and the demand. The travel cost function
has the form c(x,·) : R
|R|
+ → R|R|, where |R| is the total number of routes. The demand for each OD pair depends
on the travel cost, and the demand function has the form d(x,·) : R|C| → R
|C|
+ .
Wardrop’s user equilibrium condition [59] states that for each OD pair, the travel cost for all routes utilized
must be equal and minimal. Since the ﬂow is nonnegative, this condition can be formulated as a complementarity
condition. Let ppq be the minimum travel cost for OD pair (p,q). The equilibrium condition is that
0 ≤ hr ⊥ cr(x,h)−ppq ≥ 0, r ∈ Rpq, (p,q) ∈ C. (3)
Utilizing a route–OD pair incidence matrix G ∈ R|R|×|C|, we can express demand feasibility as follows:
GTh = d(x,p). (4)
Combining (3) and (4), we characterize user equilibrium ﬂows as a mixed complementarity problem (MCP):
0|R| ≤ h ⊥ (c(x,h)−Gp) ≥ 0|R|, (5a)
GTh = d(x,p). (5b)
If we would assume that the travel cost is positive, then (5) can instead be formulated as the following nonlinear
complementarity problem (NCP) ([1, 44]):
0|R| ≤ h ⊥ (c(x,h)−Gp) ≥ 0|R|, (6a)
0|C| ≤ p ⊥
¡
GTh−d(x,p)
¢
≥ 0|C|. (6b)
We can also provide a link ﬂow representation of the user equilibrium condition. Let v ∈ R|E| be a vector of link
ﬂows, and let tl(x,v) be the link travel cost for l ∈ E. If we assume that the travel costs are additive, and introduce
a route–link incidence matrix L ∈ {0,1}|E|×|R|, the link travel cost is related to the route travel cost through the
relation c(x,h) = LTt(x,v). Also, to have ﬂow conservation, we require v = Lh.
The main objective in a network design problem is to inﬂuence the travel costs and the demands such that
some criterion is optimized. The design problem can be formulated as an MPEC, since the trafﬁc equilibrium is
described by a system of mixed complementarity constraints. An example of a network design problem is given
by setting link tolls through the design parameter x ∈ Rn, with n ≤ |E|, such that the total travel cost
f(x,v) := å
l∈E
tl(x,v)vl
is minimized, and where, for a given design x, v is given by (5) and by the equation v = Lh.
The trafﬁc equilibrium model is a static model. All quantities are assumed to be an average over a time period,
and as such they are subjected to uncertainties. The travel costs t(x,v,w) and demands d(x,p,w) are to some
extent uncertain and can change depending on external factors, such as the weather. We can, and should, therefore
formulate the network design problem as an SMPEC, which gives us a design which is the best possible on average.
This problem has been studied in Patriksson [45, 46] and Birbil et al. [6].
For further information and references on trafﬁc equilibrium models, see for example [55, 44, 35]. In Section
5, we present a small numerical example on trafﬁc planning.
4Optimization of a treatment plan for radiation therapy In radiation therapy, cancerous tumors are subjected
to ionizing radiation. The objective is to eradicate the tumor while sparing the surrounding tissue and organs at
risk. We will show that MPEC models can be utilized to ﬁnd optimal radiation plans.
Radiation is delivered by a linear accelerator, and by using what is called multi-leaf collimators, the radiation
beam can be shaped such that different parts in the treatment region receive different doses. This technique of
shaping the beam is called intensity modulated radiation therapy (IMRT). Since there are millions of ways of
modulating the intensity, the most suitable radiation dose is found by optimization. The ideal dose is still often not
attainable, so the objective is to ﬁnd the best compromise achievable.
In order to parameterize the multi-leaf collimator system, the beam cross-section is subdivided into small
rectangular cells, and the variables are the intensities through each cell. We assume that any bounded, nonnegative,
intensity proﬁle is attainable by multi-leaf collimators as a total over a treatment time. If the doses y ∈ Rm scale
linearly with the intensities x ∈ X and are additive, an attainable dose is given by the equation:
y = Kx, (7)
where the inﬂuence matrix K ∈ Rm×n can be computed beforehand.
Objective functions in IMRT are either physically or biologically based. In short, a physically based function
is a function of the dose alone. It can, for example, be the quadratic deviation from a dose level sought, or the
maximum dose in a domain. A biologically based function is associated with a speciﬁc organ and measures the
biological effect of a dose. The function is constructed using a set of biological parameters which can depend on
the organ type, its size, shape etc.
An example of a biologically based function is the generalized equivalent uniform dose (gEUD) ([41]):
g(d) =
Ã
1
|J| å
j∈J
da
i
!1/a
,
where J is the set of voxels (discretized cells) in the organ. The parameter a inﬂuences the volume effect of the
dose: if a = 1, then the function measures the mean dose, and for higher values, the function value approaches the
maximum dose. For example, the spinal cord is sensitive to a maximum dose, and the volume effect is low. On the
other hand, the parotid glands are organs that are sensitive to how much volume receives a certain dose. Suitable
values for a are typically ﬁtted from clinical data. The gEUD function is attractive from several points of view,
not the least from the fact that it is convex if a ≥ 1, which is the case for organs. There are also other biologically
based functions that have been used in IMRT, for example tumor control probability (TCP) (e.g., [10]), normal
tissue complication probability (NTCP) (e.g., [57]), and P+ ([9]). Physically based objective functions are used in
the clinic, whereas recent research focuses on biologically based functions. The biological parameters are ﬁtted to
complication endpoints, and this constitutes a substantial part of the research behind biologically based functions.
If we combine an objective function with the system (7), we can formulate the optimization problem as an
MPEC, with X = [0,v]n andC = Rm, where v is a suitable upper bound on the intensities. If the objective function
is gEUD or any other convex function, the MPEC is in fact a convex problem!
The linear accelerator is able to deliver radiation to the target from several angles by the use of a gantry arm.
For some cases up to nine gantry angles are used to give a good target coverage. The angles are usually considered
ﬁxed in the optimization problem. If the choice of angles is indeed included, then the resulting optimization
problem can be formulated as a bilevel optimization problem, and thus still be formulated as an MPEC.
Radiation therapy is delivered in fractions stretching over several weeks, and although the patient is ﬁxated,
there will be variations in position over the sessions. (This is called setup errors.) Another uncertainty that affects
how good a treatment plan is in practice is patient and organ motion which will vary during a treatment session.
Combining the two, we get a position uncertainty which can be represented by a stochastic inﬂuence matrix K(w).
Olafsson and Wright [42] and Chu et al. [13], assume that the doses are stochastic, and use probabilistic constraints
to control the dose levels in the target and in the organs at risk. Chan et al. [12] use a motion probability mass
function, and assumes that the probability itself is uncertain. Using linear programming duality, they can formulate
the optimization problem as a large linear program. Baum et al. [3] use coverage probabilities for the target and
tumor as penalties in the objective functions to derive a robust treatment. Unkelbach and Oelfke [58] discuss,
from a mathematical and a physics perspective, the difference between using coverage probabilities and stochastic
programming in IMRT optimization.
Position uncertainty can be modeled within the SMPEC framework, and for this application the ESMPEC
model (cf. Section 2.2) is not suitable, since that would imply using a mean dose, 0 = E[y−Kx] = y−E[Kx], and
5the effect of the motion would be disregarded. An optimal solution to the SMPEC model, in contrast, gives a
treatment plan which is the best in a mean sense.
Biological uncertainty can also be incorporated in an SMPEC model through the objective function. An optimal
solution in that case is the best in a population perspective. Functions based on the biological effect have certain
advantages over physically based functions, but they rely on the accuracy of the biological parameters which are
ﬁtted from data in medical studies. For example, the dose–volume effect for the bladder is uncertain (see, e.g.,
[39, 24]), which has an impact on the parameter a in the gEUD function.
In K˚ aver et al. [27] and Lian and Xing [30], stochastic programming is used for the optimization of a treatment
plan when there are uncertainties in the biological parameters. In both papers, the expected value of the objective
functions is minimized. K˚ aver et al. use the objective P+, which is a non-convex objective function, and Lian
and Xing use an objective function based on gEUD. Lian and Xing report that the result strongly depends on the
underlying probability distribution.
For more general information on IMRT, see [60, 33, 11]. In Section 5, we present a numerical example.
3 Solution stability
We are interested in the stability of optimal solutions to (SMPECW) with respect to changes in the probability
distribution. Such results have value both from a computational and a theoretical viewpoint. If the problem
is stable, then it can be approximated by using discrete probability measures, resulting in a ﬁnite-dimensional
problem. From a theoretical point of view, we deduct that the problem is robust. We analyze the stability of
globally optimal solutions (Theorem 3.1) as well as of stationary solutions (Theorem 3.2).
3.1 Stability of globally optimal solutions
We ﬁrst analyze the stability of globally optimal solutions. This is foremost motivated by simplicity. For global op-
tima we can relate the perturbations of the probability distribution to changes in the objective value. For stationary
solutions, this becomes more problematic.
The result of stability of globally optimal solutions is particularly interesting for convex problems, where we
can ﬁnd global optima in practice. In Section 2.2, we presented a convex model in the application of radiation
therapy.
Let {Pk} be a sequence of probability measures deﬁned on B(W). Consider the associated sequence of opti-
mization problems to
(SMPECW)k
8
> > > <
> > > :
minimize
(x,y(·))
Ew[f(x,y(w),w)] :=
Z
W
f(x,y(w),w)Pk(dw),
subject to x ∈ X,
−F(x,y,w) ∈ NC(y), Pk-a.s.
The problem differs only to (SMPECW) in the choice of probability distribution. Let val(P) denote the optimal
value of problem P. The following result shows the stability of globally optimal solutions. The corresponding
result in the context of topology optimization in structural mechanics can be found in [18] and to network design
under trafﬁc equilibrium in [45, 46]. The proof presented here is similar.
Theorem 3.1 (global stability of optimal solutions) SupposethatAssumptions(A)hold, thatthemappingF(x,·,w)
is strictly monotone in y for each x ∈ X and w ∈ W, and that the sequence {Pk} of probability measures weakly
converges to P. Also suppose that for each k, (xk,yk(·)) solves (SMPECW)k. Then, each limit point (and there is at
least one) of the sequence {(xk,yk(·))} is an optimal solution to (SMPECW).
PROOF. Consider an optimal solution (x∗,y∗(·)) to (SMPECW). Since F is strictly monotone in y, y is continuous
in x and w. By (A3), any sequence of feasible designs and responses is bounded and hence has a limit point.
The optimal solution to (SMPECW) is moreover feasible in (SMPECW)k for all k. It follows that val(SMPECW) ≥
limsupk→¥val(SMPECW)k.
Next, let {(xk,yk(·))} be a sequence of optimal solutions to (SMPECW)k. By (A3), this sequence is bounded.
Denote any limit point (¯ x, ¯ y(·)). It is feasible for almost any w in (SMPECW). Using the lower semi-continuity of
6f and Fatou’s lemma we get
val(SMPECW) ≤
Z
W
f(¯ x, ¯ y(w),w)p(w)dw
≤
Z
W
liminf
k→¥
f(xk,yk(w),w)p(w)dw
≤ liminf
k→¥
Z
W
f(xk,yk(w),w)pk(w)dw
= liminf
k→¥
val(SMPECW)k.
By combining the two inequalities, we get the result.
3.2 Stability of stationary solutions
Due to the non-convex nature of MPECs, it is not reasonable in general to expect algorithms to ﬁnd globally
optimal solutions. (Our application in IMRT is an exception since there are formulations that are convex.) This
fact limits the practical use of Theorem 3.1, and raises the question of stability of stationary solutions. The proof of
stability for globally optimal solutions was based on analyzing the convergence of the optimal value. For stationary
solutions we need to analyze the conditions of (local) optimality which relates to stationarity.
Optimality conditions for (SMPECW) are non-trivial to formulate due to the presence of the variational in-
equality. Under certain conditions the response variable y can be treated as an implicit variable; this reduces the
complexity of formulating optimality conditions for the SMPEC. This technique is used by Outrata [43] for the
MPEC, which has inspired the proof approach below.
The following will be utilized in addition to Assumptions A.
Assumptions B
(B1) The function f is Lipschitz continuous in (x,y);
(B2) the mapping F(x,·,w) is differentiable and uniformly strongly monotone on C for each x ∈ X and w ∈ W,
i.e.,
(F(x,y1,w)−F(x,y2,w))T(y1−y2) ≥ cky1−y2k2, ∀y1,y2 ∈C,
where c > 0 is independent of x and w;
(B3) X = {x ∈ Rn | gi(x) ≤ 0, i = 1,...,p}, and each function gi is continuously differentiable;
(B4) the Mangasarian–Fromovitz constraint qualiﬁcation (MFCQ) holds for all x ∈ X.
Let us quickly place the assumptions in the context of our two applications. The objective function in both
applications is usually analytic in the design variable and the response variable, so Assumption (B1) is fulﬁlled.
For the application in radiation therapy, F(x,y(w),w) = K(w)x−y(w), where we consider the inﬂuence matrix
K to depend on the stochastic variable w, and so Assumption (B2) is trivially fulﬁlled. For trafﬁc equilibrium, we
refer to Patriksson [45, 46] for details on the mapping F. Furthermore, conditions (B3) and (B4) are natural to
assume for the two applications.
If Assumptions (B1) and (B2) hold, then ([48]) there exists a locally Lipschitz continuous, single-valued solu-
tion map (x,w) 7→ s(x,w) with
y = s(x,w), s(x,w) ∈ S(x,w).
With this property, we can rewrite (SMPECW) and (SMPECW)k as one-level problems:
(SNLPW)
8
<
:
minimize
x
Ew[f(x,s(x,w),w)] :=
Z
W
f(x,s(x,w),w)P(dw),
subject to x ∈ X,
respectively,
(SNLPW)k
8
<
:
minimize
x
Ew[f(x,s(x,w),w)] :=
Z
W
f(x,s(x,w),w)Pk(dw),
subject to x ∈ X.
7Before stating the optimality conditions we introduce two deﬁnitions from non-smooth analysis.
Deﬁnition 3.1 The Clarke directional derivative of a function f : Rn → R at x in the direction of h is deﬁned by
f0(x;h) := limsup
t↓0
z→x
f(z+th)− f(z)
t
.
Since f is Lipschitz continuous [Assumption (B1)], f0(·,h) is upper semi-continuous ([14, Proposition 2.1.1]).
Deﬁnition 3.2 The generalized gradient of f at x is deﬁned as the set
¶ f(x) := {x ∈ Rn | (x,h) ≤ f0(x;h)}.
If f is continuously differentiable at x then ¶ f(x) = {Ñf(x)}. If Assumptions (B3) and (B4) hold, a vector
x∗ ∈ X is a Clarke stationary solution (see [14, Theorem 6.1.1], [8, Theorem 6.1.8]) to (SNLPW) if for some vector
m ∈ R
p
+ with migi(x∗) = 0 for all i, we have
0n ∈ ¶Ew[f(x∗,s(x∗,w),w)])+Ñg(x∗)m,
where m is the vector of Lagrange multipliers.
Theorem 3.2 (stability of stationary solutions) Suppose that Assumptions (A) and (B) hold, that the sequence
{Pk} of probability measures weakly converges to P and is upper bounded by a measurable function, and that for
each k, (xk,yk(·)) is a Clarke stationary solution to (SNLPW)k. Then, each limit point (and there is at least one) of
the sequence {(xk,yk(·))} is a Clarke stationary solution to (SNLPW).
PROOF. By the assumptions, F(x,·,w) is uniformly strongly monotone, and therefore the solution map S(x,w)
is single-valued and Lipschitz continuous (cf. [48]). This enables us to use the one-level problems (SNLPW) and
(SNLPW)k. Since s and f are Lipschitz continuous, there exists a random variable k(w)≥0 such that E[k(w)]<¥
and such that for all x1,x2 ∈ X
|f(x1,s(x1,w),w)− f(x2,s(x2,w),w)| ≤ k(w)kx1−x2k. (8)
Let xk be a Clarke stationary solution to (SNLPW)k, and consider a sequence {xk} of such stationary solutions.
Since f is inf-compact [see Assumption (A3)], this sequence is bounded. Denote a limit point by x∗. Deﬁne
Ek
w[f](x) :=
R
W f(x,s(x,w),w)Pk(dw). The point xk is stationary if
0n ∈ ¶Ek
w[f](xk)+Ñg(xk)mk, (9)
and
0p ≤ mk ⊥ g(xk) ≤ 0p. (10)
Fix a direction h ∈ Rn. Then we have:
(Ek
w[f])0(x;h) =limsup
t↓0
z→x
Ek
w[f](z+th)−Ek
w[f](z)
t
=limsup
t↓0
z→x
R
W f(z+th,s(z+th,w),w)Pk(dw)−
R
W f(z,s(z,w),w)Pk(dw)
t
=limsup
t↓0
z→x
Z
W
(f(z+th,s(z+th,w),w)− f(z,s(z,w),w))
t
Pk(dw)
≤
Z
W
f0(x,s(x,w),w;h)Pk(dw) = Ek
w
£
f0(x,s(x,w),w;h)
¤
,
8where the last inequality follows by equation (8), with x1 = z and x2 = z+th, and the Lebesgue dominated conver-
gence theorem. Furthermore, we have that
limsup
k→¥
(Ek
w[f])0(xk;h) =limsup
k→¥
Z
W
f0(xk,s(xk,w),w;h)Pk(dw) (11)
≤
Z
W
limsup
k→¥
f0(xk,s(xk,w),w;h)Pk(dw)
≤
Z
W
f0(x∗,s(x∗,w),w;h)P(dw)
=E0
w[f](x∗;h),
where we use the Lebesgue dominated convergence theorem in the second equality and the upper semi-continuity
of f0 inthesecondinequality. Hence, limsupk→¥¶Ek
w[f](xk)⊂¶Ew[f](x∗). Next, wearguethatlimsupk→¥Ñg(xk)mk =
Ñg(x∗)m∗. Suppose this is not true, but kmkk → ¥. We can then deﬁne lk := mk/kmkk, and assume that lk → l∗
for some l∗ such that
l∗ ≥ 0p, kl∗k = 1.
Let I(x) := {i | gi(x) = 0} be the set of active constraint indices at x. By the deﬁnition of MFCQ, to each xk, there
exists a vector d ∈ Rn such that
Ñgi(xk)Td < 0, i ∈ I(xk), (12)
gi(xk) < 0, i / ∈ I(xk),
For i ∈ I(x∗) we must have lk
i → 0. Fix a d ∈ Rn such that a condition like (12) holds at x∗. Then, by (9) we have
0 ≤limsup
k→¥
µ
dTÑg(xk)mk
kmkk
+
(Ek
w[f])0(xk;d)
kmkk
¶
=limsup
k→¥
dTÑg(xk)lk
= å
i∈I(x∗)
l∗
i Ñgi(x∗)Td.
From the last expression and equation (12), we get
0 ≤ å
i∈I(x∗)
l∗
i Ñgi(x∗)Td ≤ − å
i∈I(x∗)
l∗
i ,
and since l∗ ≥0p, this implies that l∗ =0. This contradicts the assumption kl∗k=1, and so m∗ must be bounded.
To sum up, we have
0 ∈ limsup
k→¥
³
¶Ek
w[f](xk)+Ñg(xk)mk
´
⊂ ¶Ew[f](x∗)+Ñg(x∗)m∗
and we can therefore conclude that x∗ is a Clarke stationary solution to (SNLPW).
4 Convergence of a discretization scheme
In this section, we discuss the numerical solution of (SMPECW). The objective function is a multi-dimensional
integral which must be approximately computed in the general case. If it is discretized, it is natural to analyze
the convergence of a discretization scheme. Having established both the stability of optimal solutions and the
convergence of a numerical scheme, puts us closer to the practical use of an SMPEC model.
One approach used extensively to numerically solve stochastic programs is a Monte Carlo technique known as
Sample Average Approximation (SAA) (see, e.g., [52]). The idea is to draw N iid samples w1,...,wN and solve
9a deterministic problem for increasing values of N. We use the reformulation of (SMPEC)W into (SNLPW), and
consider the problem to
(SNLP)N
8
> <
> :
minimize
(x,yk)
ˆ fN :=
1
N
N
å
k=1
f(x,s(x,wk),wk),
subject to x ∈ X,
To establish convergence as N → ¥, the following additional conditions are required.
Assumptions C
(C1) The set X is compact and convex;
(C2) the function f(·,s(·,w),w) is regular (i.e., f is directionally differentiable and the directional derivative
coincides with the Clarke directional derivative) at x for almost any w ∈ W.
Condition (C2) is fulﬁlled if, e.g., f(·,s(·,w),w) is convex or continuously differentiable ([14]). In radiation
therapy, f(·,s(·,w),w) is continuously differentiable, and so (C2) is fulﬁlled.
The convergence proofs both for globally optimal solutions and for stationary solutions are based on the law
of large numbers. The main difference in the assumptions needed is the requirement of a regular function for
convergence of stationary solutions.
Theorem 4.1 (convergence of optimal solutions) Let Assumptions (A), (B1)–(B2) and (C1) hold. Let, for each
N, (xN,yN(·)) be an optimal solution to (SNLP)N. Then, each limit point (and there is at least one) of the sequence
{(xN,yN(·))} is an optimal solution to (SNLPW).
PROOF. The feasible set is compact by Assumption (C1), and by Assumptions (B1)–(B2), for almost every w ∈ W
the objective function f(·,·,w) is continuous. By Assumption (B2), it is also bounded from above by a (Q,P)-
integrable function and the sample is iid. Then, by [52, Proposition 7], ˆ fN converges to f w.p.1 uniformly on X.
This, in turn, by [52, Proposition 5], implies that val((SNLP)N) → val((SNLP)W) as N → ¥.
Theorem 4.2 (convergence of stationary solutions) Let Assumptions (A), (B) and (C) hold. Let, for each N,
(xN,yN(·)) be a stationary solution to (SNLP)N. Then, each limit point (and there is at least one) of the sequence
{(xN,yN(·))} is a stationary solution to (SNLPW).
PROOF. By Assumptions (A3) and (B2) the objective function is of Carath´ eodory type, and by Assumption (C1)
the set is compact and convex. By (C2) the function is also regular. Then, by [54, Theorem 7], the sequence of
stationary solutions {(xN,yN(·))} converges w.p.1 to a stationary solution of (SNLPW).
Since (SNLPW) is a reformulation of (SMPECW), the above theorems state that we also have convergence to
global optima and stationary solutions for the corresponding discretized problem to
(SMPEC)N
8
> > > > <
> > > > :
minimize
(x,yk)
ˆ fN :=
1
N
N
å
k=1
f(x,yk,wk),
subject to x ∈ X,
−F(x,yk,wk) ∈ NC(yk), k = 1,...,N.
To summarize, the results from Theorems 4.1 and 4.2 show that it is a valid approach to compute a solu-
tion to the SMPEC model through a sequence of deterministic problems. Analogous discretization schemes for
engineering applications are also studied in Evgrafov and Patriksson [18, 19].
5 Numerical examples
In this section, we present two numerical examples: trafﬁc network design and optimization of a treatment plan
in IMRT. The trafﬁc model was implemented in MATLAB R ° (MATLAB is a registered trademark of The Math-
Works, Inc.) and solved using the solver SNOPT [22]. The IMRT model was also implemented in MATLAB
using the radiation treatment planning tool CERR [15] and solved using the routine fmincon from the Optimization
Toolbox in MATLAB.
10Links Travel cost (ti)
1 50+v1
2 50+v2
3 10v3
4 10v4
5 10+v5
Table 1: The link travel costs.
5.1 Trafﬁc network design
We present a small numerical example in the application of network design under user equilibrium. The deter-
ministic example is known as Braess’ paradox (see, e.g., [55, page 75]). It demonstrates that adding an extra link
to a network can cause an increase in the total travel cost. In short, this is due to the fact that user equilibrium is
a selﬁsh optimum, and not a system optimum. Figures 1(a) and 1(b) show the network graph with four and ﬁve
links, which we will refer to as graph I and graph II, respectively.
3
1
4
2
B
A
(a) Original network.
3
1
4
2
5
A
B
(b) Network with the addition of a new
link.
Figure 1: The networks I and II.
We have one OD-pair (A,B) with a ﬁxed demand of d = 6 units. The original network has two paths, using the
links (1,4) and (2,3), respectively, and network II has three paths, using the links (1,4), (2,3) and (3,5,4), respec-
tively. Given the link travel costs given in Table 1, the user equilibrium ﬂows for network I are v = (3,3,3,3)T,
h = (3,3)T. These ﬂows give the minimum path travel cost p = 83. For network II, the user equilibrium ﬂows are
v = (2,2,2,2,2)T, h = (2,2,2)T. These ﬂows give the minimum path travel cost p = 92. Note that adding a link
to network I yields an increase in the minimum path travel cost.
The idea now is to set tolls on network II such that we minimize the total travel cost
T(x,v) =
5
å
i=1
tivi.
For the example above, we consider adding a toll x on the new link, thus altering the travel cost to
t5 = 10+v5+x,
and consider the problem to
minimize
(x,v,p,h)
T(x,v)+tx2
subject to x ∈ X,
(v,p,h) solves (5),
where X = {x ∈ R | 0 ≤ x ≤ 14} and t > 0 is a penalty parameter against setting a too high toll value. For a
sufﬁciently small value of t, the optimal solution is x∗ = 13 and the optimal total travel cost is T(x∗,v∗) = 498.
11This is the threshold value for which there will be no ﬂow on link 5, which in turn will give a lower total travel
cost.
Now, consider the case when the travel costs are stochastic. In particular, let us assume that the travel costs on
links 3 and 4 are
ti = 10vi+wi−2, i = 3,4, (13)
and that each component in w is independent and drawn from a normal distribution with mean 0 and variance 1,
i.e., w ∼ N (0,diag(1,1)). We consider the following SMPEC model to
minimize
(x,v(·),p(·),h(·))
Ew[f(x,v(w))] := Ew[T(x,v(w))]+tx2
subject to x ∈ X,
0 ≤ h(w) ⊥
¡
LTt(x,v(w))−Gp(w)
¢
≥ 0, P-a.s.,
GTh(w) = d, P-a.s.,
v(w) = Lh(w), P-a.s.,
where L and G are the route–link incidence matrix and the route–OD pair incidence matrix, respectively, for
network II. The SMPEC is solved using the discretization scheme SAA described in the previous section. Note that
the number of variables scales linearly with the number of scenarios, since we use a general nonlinear optimization
solver. This means that for 100 scenarios, the problem has 900 variables. So, even though the deterministic
problem is of small scale, the stochastic version is of large scale.
For a run with N = 500, the solver converged to the stationary solution x∗ = 14; in Figure 2 we plot histograms
of the objective values and the path travel costs.
Inordertoillustratetheinﬂuenceofthevarianceoftheuncertainparameteronthesolution, weshowinFigure3
histograms of the path travel cost for stationary solutions corresponding to four different values of the variance of
the stochastic variable. The results are not surprising: a larger variance implies a larger spread in the response.
(We note in passing that Gwinner and Raciti [23] consider the stochastic trafﬁc network equilibrium model, i.e.,
the lower-level problem in the SMPEC model, and have developed a procedure for the analytical computation of
the mean equilibrium ﬂows and their variance for the case when the travel costs are afﬁne in the ﬂow variables.)
Regarding the solution of the discretized model, we have made the natural observation that the solution time
increases with the number of scenarios, and that it also increases with the variance of the stochastic variable. We
also note that the “quality” of the stationary solutions deteriorate. Obviously these observations are based on a
single test case, and should not be considered as general conclusions.
5.2 Optimization of a treatment plan in IMRT
We consider a prostate case, where the PTV (Planned Target Volume) overlaps two critical structures, the rectum
and the bladder (see Figure 4).
We have four objectives, which are listed in Table 2. The PTV should receive a uniform dose of dP = 70 Gy
(J/kg). The rectum is considered as an organ with a serial architecture, which means that it is sensitive to the
maximum dose. The volume effect parameter for this organ is set to ar = 8.3 according to Emami et al. [17]. The
architecture of the bladder is much more uncertain. In [17], the volume effect parameter is estimated to ab = 2.
Wu et al. [61] have used ab = 6. We will consider this value as a stochastic variable, ab = ab(w), drawn from a
cut-off (below 1) normal distribution with mean m = 2 and variance s2 = 1.
In Table 3, the structure ’Unspeciﬁed’ refers to the normal tissue surrounding the other structures. We enforce
a maximum dose limit dN = 50 Gy on this structure. This is quite common in clinical practice in order to avoid
hot spots which can induce secondary cancers.
The upper limits for the gEUD for the rectum gr and for the bladder gb were computed from the treatment plan
which was used in the clinic for this patient. Note that the upper limit for the bladder is a stochastic variable since
it depends on the value of ab.
Since the structures overlap, the four objectives will be in conﬂict with each other, and it is our goal to ﬁnd a
good compromise. This is a multiple objective problem (see further Section 6), but for this example we will use a
simple scalarization of the objective functions and treat it as a single-objective problem.
Let T , B, R, N denote the voxels in the PTV, the bladder, the rectum and the normal tissue, respectively.
For a vector v ∈ Rn and a set I = {i1,...,ik} with |I| ≤ n, we use the notation vI = (vi1,...,vik)T, and v+ =
(max{0,v1},...,max{0,vn})T. Also we let e = (1,...,1)T.
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Figure 2: A histogram (N = 500) for (a) the objective values and (b) the path travel costs.
Consider the following problem, which is of the form (SMPECW):
(SIMRTW)
8
> > <
> > :
minimize
(x,d)
Ew[Q(d,w)],
subject to 0n ≤ x ≤ u,
d = Kx,
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Figure 3: Path travel costs for runs with N = 100 and with variance (a) s2
j = 0.01, (b) s2
j = 0.025, (c) s2
j = 1, and
(d) s2
j = 4, j = 1,2, for the link costs in (13). Each subﬁgure corresponds to one stationary solution.
where u ∈ Rn is an upper bound on the intensities, and the objective function Q is deﬁned as:
Q(d,w) :=
v1
2|T |(dT −s0)TS−1
0 (dT −s0)+
v2
gr
Ã
1
|R| å
j∈R
d
ar
j
!1/ar
+
v3
gb(w)
Ã
1
|B| å
j∈B
d
ab(w)
j
!1/ab(w)
+
v4
2|N |(dN −r0)T
+R−1
0 (dN −r0)+,
where v ∈ R4
+ are the weights in the scalarization, s0 = dPe, S0 = diag(s0), r0 = dNe, and R0 = diag(r0). Each
term in Q is a convex function; hence, (SIMRTW) is a convex problem. The ﬁrst term in Q measures the quadratic
deviation from target dose dP, the second and the third term are the gEUD functions for the rectum and the bladder,
respectively, and the ﬁnal term is a one-sided measure of the quadratic deviation from the maximum dose in the
unspeciﬁed tissue.
We use beams from 5 equidistant gantry angles to irradiate the tumor. The number of voxels and variables in
(SIMRTW) depend on the number of beams, the beamlet size and the geometry and resolution of the patient region.
For this case, we have 1,526,330 voxels and 336 variables. The results below are generated for the following set
14Bladder PTV
Rectum
Figure 4: A transverse CT scan.
Structure Prescription
PTV Uniform dose of dP = 70 Gy
Bladder gEUD with uncertainty
Rectum gEUD (a = 8.3) below 57 Gy
Unspeciﬁed Maximum dose of dN = 50 Gy
Table 2: Treatment parameters.
of weights: v = (10,1,1,1)T.
Wecomparetheresultoftheoptimalsolutionofasampleaverageapproximationwith50samplestotheoptimal
solution of a deterministic version, where we use ab = E[ab(w)]. The result is shown in a dose volume histogram
in Figure 5. The number of scenarios does not inﬂuence the number of variables or the number of constraints,
but it increases the complexity of the objective function. This, in turn, affects the performance of the optimization
algorithm which is a conjugate gradient method.
With a stochastic volume effect parameter, the solution is more sensitive to the maximum dose in the bladder,
and less sensitive to a mean dose. It is difﬁcult to determine the exact beneﬁt of minimizing the expected value
of the gEUD function since the actual biological response to dose is unknown. Instead we argue that the expected
valuegivesatreatmentwhichisgoodoverapopulationaverage, andthatthisisperhapsthemostsuitabletreatment.
The downside of this approach might be that the extremes are not monitored. It could be that for certain patients
in the population, this treatment can give a poor result which can outweigh the fact that it is a good treatment plan
on average. This motivates the inclusion of risk measures in the optimization problem, and is an interesting topic
for future research.
6 Stochastic multiple objective mathematical programs with equilibrium
constraints
In many practical applications several objectives should be optimized simultaneously. The optimization of a treat-
ment plan in IMRT is but one such example. In the basic setting we have two objectives: tumor control and
sparring of organs at risk. However, the objective of sparring the organs at risk can be divided into as many ob-
jectives as there are organs close to the tumor. Some of these objectives can be formulated using constraints, but
without expert knowledge of the underlying problem, it is difﬁcult to set up the problem correctly. Here is where
multi-objective optimization enters. With q objectives, the problem is formulated as that to
minimize
x∈X
(f1(x),..., fq(x)).
We recall the deﬁnitions of Pareto and weakly Pareto optimal solutions.
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Figure 5: The ﬁgure shows a dose volume histogram for the target and the risk organs. The solid lines represent
the optimal solution for the problem with a stochastic volume parameter for the bladder ab(w), and the dashed line
represents the optimal solution for the deterministic problem with ab = E[ab(w)].
Deﬁnition 6.1 A vector ¯ x ∈ X is called Pareto optimal if there is no x ∈ X such that f(x) ≤ f(¯ x) and fi(x) < fi(¯ x)
for at least one i = 1,...,q. A feasible solution ˆ x is called weakly Pareto optimal if there is no x ∈ X such that
f(x) < f(ˆ x).
The study of a multiple objective SMPEC problem appears to be new; Ye and Zhu [62], and Murdukhovich
[37, 38] have studied multi-objective optimization versions of the MPEC problem. We deﬁne the multiple objective
version of the SMPEC, the SMOPEC, for q objectives as that to
(SMOPECW)
8
> > <
> > :
minimize
(x,y(·))
(Ew[f1(x,y(w),w)],...,Ew[fq(x,y(w),w)]),
subject to x ∈ X,
−F(x,y,w) ∈ NC(y), P-a.s.
We analyze the stability of weakly Pareto optimal solutions (Theorem 6.1) and of weakly Pareto stationary solu-
tions (Theorem 6.3) below.
6.1 Stability of weakly Pareto optimal solutions to a convex problem
Let {Pk} be a sequence of probability measures deﬁned on B(W), and consider the associated sequence of opti-
mization problems to
(SMOPECW)k
8
> > <
> > :
minimize
(x,y(·))
³
Ek
w[f1(x,y(w),w)],...,Ek
w[fq(x,y(w),w)]
´
,
subject to x ∈ X,
−F(x,y,w) ∈ NC(y), Pk-a.s.,
where
Ek
w[fi(x,y(w),w)] :=
Z
W
fi(x,y(w),w)Pk(dw), i = 1,...q.
16If the set X is convex and the functions fi(·,·,w) are convex for i=1,...,q, then (SMOPEC)W is a convex problem.
Theorem 6.1 (stability of weakly Pareto optimal solutions) Suppose that Assumptions (A) hold, that the mapping
F(x,·,w) is strictly monotone for each x ∈ X and w ∈ W, that (SMOPECW) is a convex problem, and that the
sequence {Pk} of probability measures weakly converges to P. Also, suppose that for each k, (xk,yk(·)) is a weakly
Pareto optimal solution to (SMOPECW)k. Then, each limit point (and there is at least one) of the sequence
{(xk,yk(·))} is a weakly Pareto optimal solution to (SMOPECW).
PROOF. Consider a weakly Pareto optimal solution (x∗,y∗(·)) to (SMOPECW). By convexity, there exists a
l ∈ Rk
+, with a least one i = 1,...,q with li > 0, such that the solution minimizes the following single-objective
problem [16, Prop 3.10]:
(S)
8
> > > <
> > > :
minimize
(x,y(·))
q
å
i=1
Z
W
lifi(x,y(w),w)P(dw),
subject to x ∈ X,
−F(x,y,w) ∈ NC(y), P-a.s.
Fix this vector l and consider a sequence of single-objective problems to
(S)k
8
> > > <
> > > :
minimize
(x,y(·))
q
å
i=1
Z
W
lifi(x,y(w),w)Pk(dw),
subject to x ∈ X,
−F(x,y,w) ∈ NC(y), Pk-a.s.
Denote an optimal solution to (S)k by (xk,yk(·)). Since (SMOPECW) is a convex problem, so is (SMOPECW)k for
all k. By convexity, (xk,yk(·)) is a weakly Pareto optimal solution to (SMOPECW)k [16, Prop 3.9]. Now, apply
Theorem 2 with the objective function f replaced by
f(x,y(w)) :=
q
å
i=1
lifi(x,y(w),
to get the result.
6.2 Stability of weakly Pareto stationary solutions
To establish stability without the assumption of convexity, we follow the development of Section 3.2 and reformu-
late (SMOPECW) and (SMOPECW)k as one-level problems by treating y as a function of x and w: y = s(x,w).
This is possible if, in addition to the assumptions in Theorem 6.1, Assumptions (B1) and (B2) hold. We denote the
reformulations by (SMONLPW) and (SMONLPW)k, respectively:
(SMONLPW)
(
minimize
x
(Ew[f1(x,s(x,w),w)],...,Ew[fq(x,s(x,w),w)]),
subject to x ∈ X,
and
(SMONLPW)k
(
minimize
x
(Ek
w[f(x,s(x,w),w)],...,Ek
w[fq(x,s(x,w),w)]),
subject to x ∈ X.
The following theorem is a KKT characterization of weak Pareto optimality for multi-objective problems, due to
Minami [36] and Li [29].
Theorem 6.2 Consider the problem to
minimize
x
(f1(x),..., fq(x)),
subject to gj(x) ≤ 0, j = 1,...,p,
17where fi are locally Lipschitz continuous and gj ∈C1. Assume that the constraint qualiﬁcation MFCQ, (B4), holds
for all feasible solutions. Then, x∗ is a weakly Pareto optimal solution if there exist real numbers li ≥ 0 for all i,
with li > 0 for at least one i, and 0p ≤ g(x∗) ⊥ m ≥ 0p such that
0n ∈
q
å
i=1
li¶ fi(x∗)+
p
å
j=1
mjÑgj(x∗). (14)
A solution which fulﬁlls these conditions is called a weakly Pareto stationary solution. Next, we establish the
stability of weakly Pareto stationary solutions.
Theorem 6.3 (stability of weakly Pareto stationary solutions) Suppose that Assumptions (A) and (B) hold, that
the sequence {Pk} of probability measures weakly converges to P, and that for each k, (xk,yk(·)) is a weakly Pareto
stationary solution to (SMONLPW)k. Then, each limit point (and there is at least one) of the sequence {(xk,yk(·))}
is a weakly Pareto stationary solution to (SMONLPW).
PROOF. ConsideraweaklyParetostationarysolutionx∗ to(SMONLPW). ByTheorem6.2, thereexistrealnumbers
li ≥ 0 for all i, with li > 0 for at least one i, such that the conditions in Theorem 6.2 hold. Fix this value of l, and
consider a sequence {(xk,yk(·))} which is Clarke stationary to (S)k, that is,
0n ∈ ¶
Ã
q
å
i=1
lifi
!
(xk)+
p
å
i=1
miÑgi(xk).
By the properties of the generalized gradient [14, Section 2.3, Corollary 2], we have that
¶
Ã
q
å
i=1
lifi
!
(xk) ⊂
q
å
i=1
li¶ fi(xk),
for any scalars li, i = 1,...,q, so (xk,yk(·)) is also a weakly Pareto stationary solution to (SMONLPW)k. Now,
apply Theorem 3.2 to the single-objective problem (S)k with the objective function f replaced by
f(x,y(w)) :=
q
å
i=1
lifi(x,y(w),
to get the result.
7 Summary, conclusions and future research
Our main contribution in this paper is that we established that the SMPEC model is robust under the assumptions
that the solution to the lower-level equilibrium problem is unique and that we have sufﬁcient regularity conditions
on the objective function and constraints. We showed that global optima as well as stationary solutions are stable
with respect to changes in the probability distribution. If the SMPEC framework is used to model a problem of
ﬁnding a design which should be “good” on average for various scenarios, then the optimal solution to SMPEC
gives a design which is stable to changing conditions. The result on the robustness also gives a credibility to using
stochastic programming in general, since one of the criticisms on stochastic programming is that the probability
distribution is often unknown, or only partially known.
We have extended the result on robustness to an SMPEC problem with multiple objectives, which has impor-
tance for example in the application of optimization of radiation therapy plans, where we often simultaneously
face multiple objectives and uncertainties in data.
We also presented a discretization scheme, Sample Average Approximation (SAA), which is convergent and
can be used to solve the SMPEC model. The result on convergence of the SAA scheme is not new, but was included
to demonstrate that the results on robustness can be combined with a method for numerically solving the SMPEC
model.
Two numerical examples were presented: toll optimization in a simple trafﬁc network, and the optimization
of a radiation therapy treatment plan. The intention with the examples was to illustrate the effect of a stochastic
18programming approach and to compare it to a deterministic model. The optimal solution can be quite different
compared to an optimal solution where mean values of the uncertain parameters are used. It is also interesting to
see the “spread”, that is, the distribution, of the objective function value and the responses, over the scenarios.
As a future research task, it would be interesting to investigate risk measures as objectives in the SMPEC
model, as alternatives to the mean value used here. Risk measures are well motivated especially in the application
of radiation therapy, where individuals are treated. It would in particular be interesting to extend the stability results
of this paper to such a setting. We note that R¨ omisch [49] includes quantitative stability results for the conditional
value-at-risk (CVaR).
Finally, we are interested in other biological models for utilization in intensity modulated radiation therapy; a
deeper study will be presented in a future paper.
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